DrugPatentWatch Database Preview
Details for Patent: 8,795,725
Try a free trialSee Plans and Pricing
Which drugs does patent 8,795,725 protect, and when does it expire?
Patent 8,795,725 protects HORIZANT and is included in one NDA.
This patent has twenty-three patent family members in sixteen countries.
Summary for Patent: 8,795,725
| Title: | GABA analog prodrug sustained release oral dosage forms |
| Abstract: | Sustained release oral dosage forms of a gabapentin prodrug, 1-{[(.alpha.-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane acetic acid, are disclosed. The dosage forms are useful for treating or preventing diseases and disorders for which gabapentin is therapeutically effective. |
| Inventor(s): | Cundy; Kenneth C. (Redwood City, CA), Sastry; Srikonda (Sunnyvale, CA), Leung; Manshiu (Daily City, CA), Kadri; Balaji V. (Tampa, FL), Stach; Paul E. (Plymouth, MN) |
| Assignee: | XenoPort, Inc. (Santa Clara, CA) |
| Application Number: | 11/269,045 |
| Prior Art and Litigation Support | Order Prior Art and Litigation support for Patent 8,795,725 |
|
Patent Claim Types: see list of patent claims | Compound; Dosage form; Composition; Use; |
Drugs Protected by US Patent 8,795,725
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-002 | Dec 13, 2011 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | MANAGEMENT OF POSTHERPETIC NEURALGIA (PHN) IN ADULTS | ➤ Sign Up | |||
| Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-002 | Dec 13, 2011 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | TREATMENT OF MODERATE-TO-SEVERE PRIMARY RESTLESS LEG SYNDROME IN ADULTS | ➤ Sign Up | |||
| Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-001 | Apr 6, 2011 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | MANAGEMENT OF POSTHERPETIC NEURALGIA (PHN) IN ADULTS | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
International Family Members for US Patent 8,795,725
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2005301970 | ➤ Sign Up | |||
| Brazil | PI0517227 | ➤ Sign Up | |||
| Canada | 2584338 | ➤ Sign Up | |||
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
